-
Midatech Completes Acquisition Zuplenz From Galena Biopharma, Notes Potential $4.6 Billion Market
Wednesday, December 30, 2015 - 10:05am | 141Midatech Pharma PLC (NASDAQ: MTP), a small-cap nano-medicine company, announced on Wednesday it has completed the acquisition of Zuplenz from Galena Biopharma Inc (NASDAQ: GALE). Midatech will pay Galena Biopharma $3.75 million upfront with milestone payments of up to $26 million depending on...